Profile data is unavailable for this security.
About the company
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
- Revenue in USD (TTM)150.71m
- Net income in USD-40.85m
- Incorporated2008
- Employees344.00
- LocationSI-BONE Inc471 El Camino Real, Suite 101SANTA CLARA 95050United StatesUSA
- Phone+1 (408) 207-0700
- Fax+1 (408) 557-8312
- Websitehttps://si-bone.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | 202.86m | -61.52m | 500.87m | 516.00 | -- | 4.77 | -- | 2.47 | -0.9924 | -0.9924 | 3.27 | 1.68 | 0.8951 | 1.08 | 8.25 | 393,141.50 | -27.15 | -- | -32.22 | -- | 80.61 | -- | -30.33 | -- | 2.98 | -- | 0.3366 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Surmodics Inc | 126.08m | -11.54m | 548.71m | 376.00 | -- | 4.61 | -- | 4.35 | -0.8145 | -0.8145 | 8.90 | 8.33 | 0.6922 | 2.20 | 6.03 | -- | -6.34 | -3.99 | -7.22 | -4.66 | 73.81 | 80.25 | -9.15 | -6.26 | 3.22 | -4.22 | 0.1991 | -- | -4.91 | 4.73 | -651.43 | -- | -12.34 | -- |
| AxoGen Inc | 173.48m | -16.54m | 554.89m | 426.00 | -- | 5.80 | -- | 3.20 | -0.3829 | -0.3829 | 4.01 | 2.18 | 0.9117 | 1.62 | 7.43 | 407,237.10 | -8.69 | -13.92 | -9.93 | -15.84 | 76.98 | 79.74 | -9.53 | -20.28 | 2.32 | -2.94 | 0.3297 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Butterfly Network Inc | 76.22m | -98.51m | 558.22m | 225.00 | -- | 3.07 | -- | 7.32 | -0.4708 | -0.4708 | 0.3627 | 0.8537 | 0.2543 | 0.6416 | 4.45 | 338,755.60 | -32.87 | -- | -38.53 | -- | 29.60 | -- | -129.25 | -- | 2.95 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Quanterix Corp | 129.33m | -39.71m | 579.52m | 441.00 | -- | 1.72 | -- | 4.48 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Varex Imaging Corp | 832.70m | 34.20m | 581.60m | 2.30k | 31.09 | 0.9997 | 8.55 | 0.6985 | 0.4574 | 0.4574 | 16.46 | 14.22 | 0.6758 | 1.95 | 5.28 | 346,958.30 | 2.82 | 0.9913 | 3.33 | 1.18 | 32.16 | 31.70 | 4.17 | 1.36 | 1.89 | 2.00 | 0.4271 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Paragon 28 Inc | 235.44m | -59.07m | 597.06m | 430.00 | -- | 4.07 | -- | 2.54 | -0.7132 | -0.7132 | 2.84 | 1.76 | 0.7703 | 0.6049 | 6.63 | 547,539.60 | -19.33 | -- | -23.48 | -- | 76.67 | -- | -25.09 | -- | 1.70 | -5.30 | 0.4295 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Simulations Plus Inc | 70.01m | 9.95m | 613.86m | 243.00 | 62.50 | 3.36 | 39.30 | 8.77 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| Orthopediatrics Corp | 189.67m | -28.44m | 622.79m | 247.00 | -- | 1.68 | -- | 3.28 | -1.24 | -1.24 | 8.26 | 15.32 | 0.4116 | 0.4509 | 4.71 | 767,906.90 | -6.17 | -5.40 | -6.78 | -5.93 | 73.68 | 75.09 | -15.00 | -15.92 | 3.68 | -29.11 | 0.1638 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Pacific Biosciences of California Inc | 188.87m | -400.38m | 626.82m | 796.00 | -- | 1.27 | -- | 3.32 | -1.50 | -1.50 | 0.7099 | 1.81 | 0.1125 | 2.05 | 6.69 | 237,275.10 | -23.85 | -16.19 | -26.63 | -17.81 | 26.01 | 37.35 | -211.99 | -136.21 | 7.14 | -22.46 | 0.6444 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| SI-Bone Inc | 150.71m | -40.85m | 638.75m | 344.00 | -- | 3.86 | -- | 4.24 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Mesa Laboratories Inc | 223.71m | -250.31m | 642.83m | 736.00 | -- | 4.26 | -- | 2.87 | -46.43 | -46.43 | 41.43 | 27.87 | 0.4131 | 2.51 | 6.29 | 303,956.50 | -46.23 | -9.20 | -50.62 | -9.88 | 62.27 | 60.60 | -111.89 | -28.33 | 1.37 | 1.33 | 0.5848 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Iradimed Corp | 71.31m | 18.63m | 715.67m | 148.00 | 38.67 | 8.58 | 36.79 | 10.04 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Orthofix Medical Inc | 771.65m | -120.49m | 741.74m | 1.63k | -- | 1.41 | -- | 0.9458 | -3.21 | -3.21 | 20.55 | 14.35 | 0.8654 | 1.17 | 6.49 | 479,956.60 | -13.51 | -8.88 | -16.22 | -10.96 | 67.18 | 72.37 | -15.62 | -9.28 | 1.13 | -4.94 | 0.2005 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Standard Biotools Inc | 155.90m | -170.60m | 800.36m | 534.00 | -- | 1.64 | -- | 5.13 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Figs Inc | 548.65m | 10.84m | 816.71m | 354.00 | 81.00 | 2.01 | 49.31 | 1.49 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
Data as of Nov 08 2024. Currency figures normalised to SI-BONE Inc's reporting currency: US Dollar USD
54.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Advisory LLCas of 30 Jun 2024 | 4.15m | 9.94% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 3.24m | 7.77% |
| First Light Asset Management LLCas of 30 Jun 2024 | 2.47m | 5.93% |
| Champlain Investment Partners LLCas of 30 Jun 2024 | 2.44m | 5.86% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 2.32m | 5.56% |
| American Century Investment Management, Inc.as of 30 Sep 2024 | 2.14m | 5.14% |
| Granahan Investment Management, LLCas of 30 Jun 2024 | 1.76m | 4.23% |
| Bellevue Asset Management AGas of 30 Jun 2024 | 1.39m | 3.33% |
| Paradigm Capital Management, Inc.as of 30 Jun 2024 | 1.35m | 3.24% |
| Silvercrest Asset Management Group LLCas of 30 Jun 2024 | 1.29m | 3.10% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
